title: The fate of renal allografts treated with OKT3 for steroid-resistant rejection.
authors.affiliation: Renal Transplant Unit, Hospital de Clínicas de Porto Alegre, Brazil.
authors.forename: F V
authors.initials: FV
authors.lastname: Veronese
authors.forename: L F
authors.initials: LF
authors.lastname: Gonçalves
authors.forename: L L
authors.initials: LL
authors.lastname: Vilarinho
authors.forename: V S
authors.initials: VS
authors.lastname: Macedo
authors.forename: R C
authors.initials: RC
authors.lastname: Manfro
mesh_terms: D000328:Adult; D004351:Drug Resistance; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012086:Reoperation; D013256:Steroids / Q000627:therapeutic use; D015996:Survival Rate; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D013256:Steroids